Hua Medicine has figured out how to bring type 2 diabetes mellitus into long-term and sustained remission.
Finerenone for the treatment of diabetic nephropathy, a chronic kidney disease associated with type 2 diabetes mellitus.
Faricimab by Roche is a strong competitor to Eylea.
Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Gefapixant will reduce cough frequency, thereby improving patients’ quality of life.